Poor outcome in progressive sclerosing cholangitis after septic shock

 

 Buy Article Permissions and Reprints

Background and study aims: Progressive sclerosing cholangitis after septic shock is an increasingly diagnosed disease entity. We evaluated the outcome after long-term follow-up of 29 patients treated in our institution between 1995 and 2007.

Patients and methods: Patients with cholestatic liver disease without evidence of pre-existing hepatobiliary disease and who previously required long-term treatment in an intensive care unit for septic shock due to following reasons were included in the study: severe trauma (n = 10; five with burn injury and five following accident), cardiac operation (n = 9), bacterial infection (n = 5), sigmoidectomy (n = 2), operation of aortic aneurysm (n = 3).

Results: In all patients, endoscopic retrograde cholangiopancreatography showed multiple stenoses, pre-stenotic dilatations, and in part rarefication of intrahepatic small bile ducts. The bile ducts were partially filled by black-pigmented or necrotic material. In 18 of 29 patients, liver biopsies were performed and showed fibrosing cholangitis. The endoscopic therapy comprised removal of occluding material, dilation of stenoses, and intermittent stenting if necessary. All endoscopic procedures were done under antibiotic prophylaxis. During follow-up, 19 of the 29 patients died. Three patients received orthotopic liver transplantation. Four patients have been registered for transplantation, and the remaining three patients show signs of severe cholestasis. The actuarial estimate (Kaplan-Meier) indicated a survival free of liver transplantation of 55 % after 1 year, and only 14 % after 6 years. The median survival was 1.1 years.

Conclusions: Progressive sclerosing cholangitis after septic shock is a recently described disease characterized by extremely short survival free of liver transplantation. This disease should be considered in patients who develop cholestasis following treatment of septic shock in an intensive care unit.

References

• 1 Engler S, Elsing C, Flechtenmacher C. et al . Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders.  Gut. 2003;  52 688-693
  CrossrefPubMedGoogle Scholar
• 2 Benninger J, Grobholz R, Oeztuerk Y. et al . Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.  World J Gastroenterol. 2005;  11 4199-4205
  PubMedGoogle Scholar
• 3 Jaeger C, Mayer G, Henrich R. et al . Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up.  Endoscopy. 2006;  38 730-734
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Gossard A A, Angulo P, Lindor K D. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.  Am J Gastroenterol. 2005;  100 1330-1333
  CrossrefPubMedGoogle Scholar
• 5 Abdalian R, Heathcote E J. Sclerosing cholangitis: a focus on secondary causes.  Hepatology. 2006;  44 1063-1074
  CrossrefPubMedGoogle Scholar
• 6 de Carpi J M, Tarrado X, Varea V. Sclerosing cholangitis secondary to hepatic artery ligation after abdominal trauma.  Eur J Gastroenterol Hepatol. 2005;  17 987-990
  CrossrefPubMedGoogle Scholar
• 7 Hohn D, Melnick J, Stagg R. et al . Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.  J Clin Oncol. 1985;  3 98-102
  PubMedGoogle Scholar
• 8 Sebagh M, Farges O, Kalil A. et al . Sclerosing cholangitis following human orthotopic liver transplantation.  Am J Surg Pathol. 1995;  19 81-90
  CrossrefPubMedGoogle Scholar
• 9 Tsimoyiannis E C, Grantzis E, Moutesidou K. et al . Secondary sclerosing cholangitis: after injection of formaldehyde into a hyatid cyst in the liver.  Eur J Surg. 1995;  161 299-300
  PubMedGoogle Scholar
• 10 Heneghan M A, Sylvestre P B. Cholestatic diseases of liver transplantation.  Semin Gastrointest Dis. 2001;  12 133-147
  PubMedGoogle Scholar
• 11 Chand N, Sanyal A J. Sepsis-induced cholestasis.  Hepatology. 2007;  45 230-241
  CrossrefPubMedGoogle Scholar
• 12 Gelbmann C M, Rümmele P, Wimmer M. et al . Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.  Am J Gastroenterol. 2007;  102 1221-1229
  CrossrefPubMedGoogle Scholar
• 13 Bambha K, Kim W R, Talwalkar J. et al . Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.  Gastroenterology. 2003;  125 1364-1369
  CrossrefPubMedGoogle Scholar
• 14 Batts K P. Ischemic cholangitis.  Mayo Clin Proc. 1998;  73 380-385
  CrossrefPubMedGoogle Scholar
• 15 Le Thi Huong D, Valla D, Franco D. et al . Cholangitis associated with paroxysmal nocturnal hemoglobinuria: another instance of ischemic cholangiopathy?.  Gastroenterology. 1995;  109 1338-1343
  CrossrefPubMedGoogle Scholar
• 16 O’Mahony C A, Vierling J M. Etiopathogenesis of primary sclerosing cholangitis.  Sem Liv Dis. 2006;  26 3-21
  PubMedGoogle Scholar

H. Kulaksiz, MD

University Hospital Ulm
Department of Internal Medicine
Division of Gastroenterology

Robert-Koch-Str. 8
D-89081 Ulm
Germany

Fax: +49-731-50044502

Email: hasan.kulaksiz@uniklinik-ulm.de